Core Viewpoint - Scienture Holdings, Inc. is actively participating in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025, showcasing its focus on developing and commercializing specialty pharmaceutical products to meet unmet market needs [1][4]. Company Overview - Scienture Holdings, Inc. (NASDAQ: SCNX) is a holding company for pharmaceutical operating companies, emphasizing enhanced value for patients, physicians, and caregivers through novel specialty products [1][6]. - The company operates through its subsidiary, Scienture, LLC, which is dedicated to developing unique specialty products across various therapeutic areas and market segments [6]. Conference Participation - Narasimhan Mani, President and co-CEO, will present on December 9, 2025, at 2:00 PM EST, with Shankar Hariharan, Executive Chairman and co-CEO, participating in one-on-one investor meetings on December 10 [2]. - The live webcast of the presentation will be available online, with a replay accessible afterward [3]. Event Details - The iAccess Alpha conference features high-potential small and micro-cap companies, providing a platform for webcast presentations and one-on-one meetings with pre-qualified investors [4][5].
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025